Sanofi Consumer Healthcare India growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr
Revenue+21.3%
EBITDA+14.2%
Net Income+32.7%
EPS (adj.)+32.7%
Total Assets+26.8%
Total Equity+40.7%
Free Cash Flow−37.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹7,642 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
Revenue+21.3
EBITDA+14.2
Net Income+32.7
EPS (adj.)+32.7
Total Assets+26.8
Total Equity+40.7
Free Cash Flow-37.1
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.